Risk assessment of "other substances" – L-serine. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety. VKM report 2016:59
dc.contributor.author | Stea, Tonje Holte | |
dc.contributor.author | Frøyland, Livar | |
dc.contributor.author | Haugen, Margaretha | |
dc.contributor.author | Henjum, Sigrun | |
dc.contributor.author | Holvik, Kristin | |
dc.contributor.author | Løvik, Martinus | |
dc.contributor.author | Skålhegg, Bjørn Steen | |
dc.contributor.author | Strand, Tor A | |
dc.contributor.author | Tell, Grethe S. | |
dc.contributor.author | Iversen, Per Ole | |
dc.coverage.spatial | Norway | nb_NO |
dc.date.accessioned | 2018-04-27T11:17:56Z | |
dc.date.available | 2018-04-27T11:17:56Z | |
dc.date.created | 2017-10-17T14:27:06Z | |
dc.date.issued | 2016 | |
dc.identifier.isbn | 978-82-8259-249-9 | |
dc.identifier.uri | http://hdl.handle.net/11250/2496363 | |
dc.description.abstract | At the request of the Norwegian Food Safety Authority, the Norwegian Scientific Committee for Food Safety (VKM) has characterised the risk of daily doses of 50, 500, 1000, 1250, 1500 and 1750 mg/day L-serine in food supplements. In the absence of long-term studies in healthy individuals, VKM used a NOAEL of 3000 mg/kg bw per day from a 90-days toxicological study in rodents. • In adults (≥18 years), the specified doses 50, 500, 1000, 1250, 1500 and 1750 mg/day L-serine in food supplements are unlikely to cause adverse health effects. • In adolescents (14 to < 18 years), the specified doses 50, 500, 1000, 1250, 1500 and 1750 mg/day L-serine in food supplements are unlikely to cause adverse health effects. • In children (10 to < 14 years), the specified doses 50, 500, 1000, 1500 and 1800 mg/day L-serine in food supplements are unlikely to cause adverse health effects. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Norwegian Scientific Committe for Food Safety (VKM) | nb_NO |
dc.relation.ispartof | VKM Report | |
dc.relation.ispartofseries | VKM Report; | |
dc.relation.uri | https://vkm.no/download/18.645b840415d03a2fe8f25ccf/1502801553571/5acd2bd54c.pdf | |
dc.subject | Serine | nb_NO |
dc.subject | food suplement | nb_NO |
dc.subject | adverse health effect | nb_NO |
dc.subject | negative health effect | nb_NO |
dc.subject | Norwegian Food Safety Authority | nb_NO |
dc.subject | Norwegian Scientific Committee for Food Safety | nb_NO |
dc.subject | other substances | nb_NO |
dc.subject | risk assessment | nb_NO |
dc.subject | VKM | nb_NO |
dc.title | Risk assessment of "other substances" – L-serine. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety. VKM report 2016:59 | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.source.pagenumber | 36 | nb_NO |
dc.source.issue | 59 | nb_NO |
dc.identifier.cristin | 1505217 | |
cristin.unitcode | 1991,0,0,0 | |
cristin.unitname | Sykehuset Innlandet HF | |
cristin.ispublished | true | |
cristin.fulltext | original |
Tilhørende fil(er)
Denne innførselen finnes i følgende samling(er)
-
Publikasjoner fra Cristin - Sykehuset Innlandet HF [517]
Open arkiv av Cristin publikasjoner